1ShindohJ, HasegawaK, InoueY, IshizawaT, NagataR, et al. Risk factors of post-operative recurrence and adequate surgical approach to im- prove long-term outcomes of hepatocellular carcinoma. HPB ( Ox- ford) ,2013,15(1) :31 -9.
2Casaccia M, Andorno E, Di Domenico S, et al. Laparoseopic resec- tion of hepatocellular carcinoma. Considerations on lesions in the pos- terosuperior segments of the liver. Ann Ital Chir,2012,83 (6) :503 - 8.
4Germani G, Pleguezuelo M, Gurusamy K, et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injec- tion for hepatocelullar carcinoma: a meta-analysis. J Hepatol,2010, 52(3) :380 -8.
5Kudo M, Ueshima K, Arizumi T. Real - life clinical practice with sorafenib in advanced hepatocellular carcinoma: a single-center expe- rience. Dig Dis,2012,30(6) :609 - 16.
3Jemal A. et al. Global cancer statistics,CA Cancer J Clin. 2011,61 (2) :69 -90.
4Chen M S,Lj J Q, Ljang H H,et al. Comparison of effcts of Percutaneous radiofrequency ablation and surgical resction on small hepato- ceullular carcinoma. Zhonghua Yixue Zazhi,2005.85 (2) :80 - 83.
6Liao G S, Yu C Y, Shih M L, et al. Radiofrequency ablation after transartcrial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol 2008 ; 34( 1 ) : 61 -66.
7Morrs D L, Horton M D, Dilley A V. et al. The treatment of hepatic metastasis by cryotherapy and regional eytotoxic perfusion. Gut, 1993, 34(9) :1156 - 1157.
8Vehri A, Moretto P, Doriguzzi A,et al. Radiofrequency thermal ablation(RFA) after transarterial chemoemblization(TACE) as combined therapy for unresectable non -early hepatocellular carcinoma( Hcc ). Eur Radio1,2006,16 (3) :661 - 669.
9Sugimori K, Nozawa A, Morimdto M, et al. Extension of radiofrequency ablation of tile Iiver by transcatheter arterial embolization witll iodized oil and gelatin sponge:results in a pig model. J Vasc Interv Radio1,2005 ,16 :849 - 856.
